BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong EX-3.1 2 ex3-1.htm EX-3.1] [Biostar Pharmaceuticals to Effect Reverse Stock Split XIANYANG, China, February 5, 2016 -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“Biostar” or “the Company”), a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China, today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-7, with anticipated trading] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 4, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T17:39:41+00:00 February 5th, 2016|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

VIPS [Vipshop] CORRESP: February 5, 2016 VIA EDGAR William H. Thompson,

[February 5, 2016 VIA EDGAR William H. Thompson, Accounting Branch Chief Re: Vipshop Holdings Limited Form 20-F for Fiscal Year Ended December 31, 2014 Filed April 24, 2015 (File No. 1-35454) Dear Mr. Thompson, Mr. Watson and Ms. Silvio: * Item 5. Operating and Financial Review and Prospects Note 19 Earnings (loss) Per Share, page F-41 1. We reviewed your]

By | 2016-04-01T10:58:12+00:00 February 5th, 2016|Categories: Chinese Stocks, VIPS, Webplus ver|Tags: , , , , , |0 Comments

SYUT [Synutra International] 8-K: Synutra Reports Third Quarter Fiscal 2016 Financial Results

[Synutra Reports Third Quarter Fiscal 2016 Financial Results ~Net Sales of $109 million ~Nutritional Food sales of $96 million Qingdao, China and Rockville, Md. – February 5, 2016 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced financial results for] []

By | 2016-03-13T10:07:43+00:00 February 5th, 2016|Categories: Chinese Stocks, SYUT, Webplus ver|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] SC 13G/A: (Original Filing)

[S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Jordan Wu 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP o (a) (b) o 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Republic of China Number of Shares Beneficially Owned By Each Reporting Person With 5 SOLE VOTING POWER 158,398 (See item 4) 6]

By | 2016-03-15T22:29:53+00:00 February 5th, 2016|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

YOKU [YOUKU TUDOU] SC 13E3/A: (Original Filing)

[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY February 5, 2016 Youku Tudou Inc. Shareholders of Youku Tudou Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of the shareholders of Youku Tudou Inc. (the "Company") to be held on March 14, 2016] []

EDU [New Oriental Education & Technology] SC 13G/A: (Original Filing)

[2. Check the Appropriate Box if a Member of a Group (See Instructions): 3. 4. Citizenship or Place of Organization: Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power: 0 6. Shared Voting Power: 17,220,052 ADR 7. Sole Dispositive Power: 0 8. Shared Dispositive Power: 17,220,052 ADR 9. Aggregate Amount Beneficially Owned by Each Reporting]

By | 2016-03-26T21:40:33+00:00 February 5th, 2016|Categories: Chinese Stocks, EDU, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION

[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong EX-3.1 2 ex3-1.htm EX-3.1] [Biostar Pharmaceuticals to Effect Reverse Stock Split XIANYANG, China, February 5, 2016 -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“Biostar” or “the Company”), a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China, today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-7, with anticipated trading] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 4, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T17:41:12+00:00 February 5th, 2016|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

KUTV [Ku6 Media] 6-K: (Original Filing)

[Ku6 Media Announces Retention of Special Committee Legal Counsel and Financial Advisor BEIJING, China, February 5, 2016 — Ku6 Media Co., Ltd. (“Ku6 Media” or the “Company,” NASDAQ: KUTV), a leading internet video company focused on User Generated Content in China, today announced that in response to the preliminary non-binding proposal letter dated February 1, 2016 (the “Proposal”) received by] [FORM 6-K Ku6 Media Co., Ltd. Building 6, Zhengtongchuangyi Centre Fax number: +86 10 5758-6834 x o Form 20-F o o o x Ku6 Media Co., Ltd. Jason Ma Acting Chief Financial Officer February 5, 2016 Description]

By | 2016-04-01T13:41:39+00:00 February 5th, 2016|Categories: Chinese Stocks, KUTV, SEC Original|Tags: , , , , , |0 Comments

SYUT [Synutra International] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended December 31, 2015 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x No o x No o Large accelerated filer o Accelerated filer x Non-accelerated filer] [CERTIFICATION I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Ning Cai, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [SYNUTRA INTERNATIONAL, INC. Certification Liang Zhang Chief Executive Officer] [SYNUTRA INTERNATIONAL, INC. Certification Ning Cai Chief Financial Officer]

By | 2016-03-13T10:09:01+00:00 February 5th, 2016|Categories: Chinese Stocks, SEC Original, SYUT|Tags: , , , , , |0 Comments
Skip to toolbar